Atlas Trials

Evaluation of the Safety and Efficacy of LB-DTK-BKV in Patients With BK Virus-Associated Hemorrhagic Cystitis Following Allogeneic Hematopoietic Stem Cell Transplantation

Clinical trial NCT07638332 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07638332
Sponsor
LucasBio
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hemorrhagic Cystitis
Start date
2026-09-01
Primary completion
2028-03-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.